Natural Biocon (India) Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	0.45	1.53	1.79	0.66	0.03
Depreciation & Amortization	0.01	-	-	-	-
Other Operating Activities	-0.05	-	-	0.15	-
Change in Accounts Receivable	-7.9	-42.16	-1.36	0.26	0.98
Change in Inventory	-0.06	7.55	-8.61	-	-
Change in Accounts Payable	20.52	31.83	9.93	0.23	-
Change in Other Net Operating Assets	-	-	0.35	0.65	2.23
Operating Cash Flow	12.97	-1.25	2.1	1.94	3.24
Operating Cash Flow Growth	-	-	8.40%	-40.14%	112.61%
Investment in Securities	-211.11	-	-	-	-
Investing Cash Flow	-211.11	-	-	-	-
Short-Term Debt Issued	2.18	-	-	-	-
Total Debt Issued	2.18	-	-	-	-
Long-Term Debt Repaid	-	-0.88	-0.19	-1.54	-3.22
Net Debt Issued (Repaid)	2.18	-0.88	-0.19	-1.54	-3.22
Issuance of Common Stock	144.1	-	-	-	-
Other Financing Activities	50.44	-	-	-	-
Financing Cash Flow	196.71	-0.88	-0.19	-1.54	-3.22
Miscellaneous Cash Flow Adjustments	-	-	-	1.32	-
Net Cash Flow	-1.43	-2.13	1.92	1.72	0.03
Cash Income Tax Paid	0.15	0.73	0.68	0.07	0.01
Levered Free Cash Flow	12.95	-11.26	1.86	11.21	0.84
Unlevered Free Cash Flow	12.95	-11.26	1.86	11.21	0.84
Change in Working Capital	12.57	-2.77	0.31	1.13	3.22

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.